mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |
mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
0.0004 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0004 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0009 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
AICAR |
GDSC1000 |
pan-cancer |
AAC |
-0.099 |
0.003 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |